Publications by authors named "Morgane Cheminant"

Claim this Profile
C
Consecutive non-Aspergillus Fungal Invasive Infections in Chronic Granulomatous Disease: Data from the French National Reference Center for Primary ImmunoDeficiencies and literature review.
Leïla Lefevre, Olivier Paccoud, Bénédicte Neven, Marie-Elisabeth Bougnoux, Mickaël Alligon, Morgane Cheminant

J Clin Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgA and IgM-enriched Immunoglobulins in Primary Immunodeficiencies: a Pilot Study.
Aurore Collet, Benjamin Coiffard, Emmanuel Ledoult, Claire Fieschi, Morgane Cheminant

J Clin Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of allogeneic hematopoietic stem cell transplantation on pulmonary complications in adults with inborn errors of immunity.
Aurélie Le Gal, Ambroise Marçais, Céline Goyard, Anne-Laure Brun, Morgane Cheminant

J Allergy Clin Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mantle cell lymphoma: how to clarify the confusion around first-line treatment?
Morgane Cheminant, Elena Robin-Marieton

Curr Opin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole Exome Sequencing of Adult Patients With Evans Syndrome Reveals Pathogenic Variants Associated With Autoimmunity.
Etienne Crickx, Jehane Fadlallah, Morgane Cheminant, Jérémie Rosain, Jérémie Dion

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Patients with Mantle Cell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy: A Descar-T Study By Lysa Group.
Marion Aymard, Morgane Cheminant, Roch Houot, Anne Cuozzo, Elodie Gat

Blood Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined PET and ctDNA response as a predictor of POD24 for follicular lymphoma after first-line induction treatment.
Alexis Claudel, Anne-Ségolène Cottereau, Emmanuel Bachy, Emmanuel Itti, Pierre Feugier, Morgane Cheminant

Blood· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed/refractory B non-Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group.
Charles Herbaux, Emmanuel Bachy, Reda Bouabdallah, Stéphanie Guidez, Olivier Casasnovas, Morgane Cheminant

Br J Haematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical manifestations, disease penetrance, and treatment in individuals with SOCS1 insufficiency: a registry-based and population-based study.
Jerome Hadjadj, Anna Wolfers, Oleg Borisov, Derek Hazard, Ronan Leahy, Morgane Cheminant

Lancet Rheumatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A low lymphocyte-to-monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis.
Pablo Mozas, Romain Ould Ammar, Loïc Chartier, Loretta Nastoupil, Emmanuel Bachy, Morgane Cheminant

Br J Haematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.
Clémentine Sarkozy, Loïc Chartier, Vincent Ribrag, Remy Gressin, Christian H Geisler, Morgane Cheminant

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab in atopic-dermatitis-like eczema associated with inborn errors of immunity: A nationwide study.
Claire Guillemin, Nathalia Bellon, Marie Jachiet, Sébastien Barbarot, Emmanuelle Bourrat, Morgane Cheminant

J Am Acad Dermatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA.
Amira Marouf, Sammara Chaubard, Raphaël Liévin, Jean-Marie Michot, Nicolas Molinari, Morgane Cheminant

Hemasphere· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages.
Jean-Sélim Driouich, Maxime Cochin, Guillaume Lingas, Léa Luciani, Cécile Baronti, Morgane Cheminant

Biomed Pharmacother· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obinutuzumab vs rituximab for transplant-eligible patients with mantle cell lymphoma.
Clémentine Sarkozy, Mary Callanan, Catherine Thieblemont, Lucie Obéric, Barbara Burroni, Morgane Cheminant

Blood· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Roch Houot, Emmanuel Bachy, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, Morgane Cheminant

Nat Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia.
Eric Durot, Damien Roos-Weil, Adrien Chauchet, Justine Decroocq, Roberta Di Blasi, Morgane Cheminant

Blood· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial.
Vincent Camus, Catherine Thieblemont, Philippe Gaulard, Morgane Cheminant, Rene-Olivier Casasnovas

J Clin Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study.
Clémentine Sarkozy, Catherine Thieblemont, Lucie Oberic, Anne Moreau, Krimo Bouabdallah, Morgane Cheminant

J Clin Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Risk of Invasive Aspergillosis in Immunocompromised Patients With Persistent SARS-CoV-2 Viral Shedding >8 Weeks, Retrospective Case-control Study.
Cléa Melenotte, Nathalie Chavarot, Anne-Sophie L'Honneur, Sylvain Bodard, Morgane Cheminant

Open Forum Infect Dis· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation is predictive of outcome in Waldenström macroglobulinemia treated by Bruton tyrosine kinase inhibitors: a multicentric real-life study.
Pierre-Edouard Debureaux, Nathalie Forgeard, Dikelele Elessa, Stéphanie Harel, Laurent Frenzel, Morgane Cheminant

Haematologica· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants.
Coralie Bloch, Jean Philippe Jais, Marine Gil, Marouane Boubaya, Yves Lepelletier, Morgane Cheminant

J Allergy Clin Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndrome.
Olivier Pellé, Solange Moreno, Myriam Ricarda Lorenz, Quentin Riller, Marita Fuehrer, Morgane Cheminant

J Allergy Clin Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Roch Houot, Emmanuel Bachy, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, Morgane Cheminant

Nat Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Roch Houot, Emmanuel Bachy, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, Morgane Cheminant

Nat Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis